Professor Huntington is a NHMRC fellow and AAS Jacques Miller Medallist currently directing the Cancer Immunotherapy Laboratory at Monash University, Australia. He is an international opinion leader on natural killer (NK) cell and cytokine biology with notable contributions to: regulatory mechanisms of IL-15R signalling, identification of human and murine NK cell differentiation pathways and identification of multiple checkpoint in NK cell activation and tumour immunity. Professor Huntington leads a research program aimed at deciphering the regulatory networks that control NK cell immunity and a drug discovery program aimed at improving the targeting and tolerability of cytokines-based therapies for oncology. Prof. Huntington is a company director, co-founder and chief scientific officer of oNKo-Innate Pty Ltd.